1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with phosphorylcholine in 21 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (phosphorylcholine) | Trials (phosphorylcholine) | Recent Studies (post-2010) (phosphorylcholine) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 5,308 | 255 | 1,893 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (14.29) | 18.7374 |
1990's | 10 (47.62) | 18.2507 |
2000's | 5 (23.81) | 29.6817 |
2010's | 3 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colard, O; Debre, P; Le Gouvello, S; Thomas, Y; Vivier, E | 1 |
De Moliner, P; Maziere, B; Ottaviani, M; Remy, P; Samson, Y | 1 |
Mookerjea, S; Nagpurkar, A; Randell, E | 1 |
Choudhury, S; Mookerjea, S; Nagpurkar, A; Randell, E | 1 |
Goldstein, BM; Kohler, CA; Schaub, RE; Sum, PE; Wissner, A | 1 |
Halonen, M; Hanahan, DJ; McManus, LM; Pinckard, RN | 1 |
Cundell, DR; Gerard, C; Gerard, NP; Idanpaan-Heikkila, I; Tuomanen, EI | 1 |
Kondo, Y; Okajima, F | 1 |
Hoffman, DR; Johnston, JM; Moya, FR; Zhao, B | 1 |
Dement'eva, EV; Dergousov, AA; Sablina, MA; Serebrennikova, GA; Ushakova, IP | 1 |
Jarvis, WD; Spangelo, BL | 1 |
Koufaki, M; Lin, SY; Makriyannis, A; Mavromoustakos, T; Theodoropoulou, E; Yang, DP | 1 |
Berger, MR; Brun, R; Kaminsky, R; Konstantinov, SM; Zillmann, U | 1 |
Fujii, S; Ikeda, K; Ikezawa, H; Morita, M; Sakurai, S; Tsukamoto, K; Yoshida, A | 1 |
Black, S; Samols, D; Wilson, A | 1 |
Damaj, BB; Jin, Y; Maghazachi, AA | 1 |
Czuprynski, CJ; Elswaifi, SF; Inzana, TJ; Kuckleburg, CJ | 1 |
Cederholm, A; Concha, H; FrostegÄrd, J; Hua, X; Su, J; Svenungsson, E | 1 |
Al-Hassani, M; Harrison, KA; Konger, RL; Murphy, RC; Rezania, S; Travers, JB; Yao, Y | 1 |
Blair, IA; Hergott, CB; Mesaros, C; Naidu, NA; Roche, AM; Weiser, JN | 1 |
Li, Y; Liang, L; Tian, X; Zhong, L; Zhou, J | 1 |
21 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and phosphorylcholine
Article | Year |
---|---|
CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone.
Topics: Antigens, Differentiation, T-Lymphocyte; Arachidonic Acids; CD2 Antigens; CD4-Positive T-Lymphocytes; Cells, Cultured; Humans; In Vitro Techniques; Phosphatidylcholines; Phosphorylcholine; Platelet Activating Factor; Receptors, Immunologic; Signal Transduction | 1992 |
Effect of alpha-glyceril-phosphorylcholine on cerebral glucose metabolism in normal volunteers.
Topics: Brain; Brain Chemistry; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Parasympathomimetics; Phosphorylcholine; Platelet Activating Factor; Tomography, Emission-Computed | 1992 |
Interaction between rat serum phosphorylcholine binding protein and platelet activating factor.
Topics: Animals; Carrier Proteins; Choline; Chromatography, Gel; Chromatography, High Pressure Liquid; Phosphorylcholine; Platelet Activating Factor; Protein Binding; Rats; Rats, Inbred Strains | 1990 |
Effect of rat phosphorylcholine-binding protein on platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Carrier Proteins; Dose-Response Relationship, Drug; Isoelectric Point; Phosphorylcholine; Platelet Activating Factor; Platelet Aggregation; Rats | 1988 |
Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety.
Topics: Animals; Blood Pressure; In Vitro Techniques; Phosphorylcholine; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred SHR; Structure-Activity Relationship | 1986 |
Acetyl glyceryl ether phosphorylcholine: platelet-activating factor.
Topics: Anaphylaxis; Animals; Basophils; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; In Vitro Techniques; Lysophosphatidylcholines; Phosphorylcholine; Platelet Activating Factor; Rabbits | 1981 |
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor.
Topics: Bacterial Adhesion; Cell Line; Endothelium, Vascular; Furans; Humans; Phosphorylcholine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Streptococcus pneumoniae; Transfection; Virulence | 1995 |
Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids.
Topics: Calcium; Cell Differentiation; Enzyme Activation; Enzyme Inhibitors; Estrenes; GTP-Binding Proteins; HL-60 Cells; Humans; Kinetics; Lysophospholipids; Neutrophils; Pertussis Toxin; Phosphorylcholine; Platelet Activating Factor; Psychosine; Pyrrolidinones; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Sphingomyelin Phosphodiesterase; Sphingosine; Type C Phospholipases; Uridine Triphosphate; Virulence Factors, Bordetella | 1995 |
Platelet-activating factor in surfactant preparations.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phospholipases A; Phospholipids; Phosphorylcholine; Platelet Activating Factor; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Trachea | 1993 |
[Synthesis of platelet activation factor analogs].
Topics: Humans; Phosphorylcholine; Platelet Activating Factor; Spectrophotometry, Infrared | 1993 |
Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Benzophenanthridines; Cells, Cultured; Enzyme Inhibitors; Interleukin-1; Interleukin-6; Lysophosphatidylcholines; Male; Phenanthridines; Phosphorylcholine; Pituitary Gland, Anterior; Platelet Activating Factor; Prolactin; Protein Kinase C; Rats; Rats, Inbred Strains; Sphingosine | 1996 |
The conformational properties of the antineoplastic ether lipid 1-thiohexadecyl-2-O-methyl-S-glycero-3-phosphocholine.
Topics: Antineoplastic Agents; Glycerol; Magnetic Resonance Spectroscopy; Micelles; Models, Molecular; Molecular Conformation; Molecular Structure; Phospholipid Ethers; Phosphorylcholine; Platelet Activating Factor | 1996 |
Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Drug Synergism; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Molecular Structure; Phenylbutazone; Phosphorylcholine; Piperidines; Platelet Activating Factor; Specific Pathogen-Free Organisms; Trypanosoma brucei brucei; Trypanosomiasis, African | 1997 |
Chromogenic assay for the activity of sphingomyelinase from Bacillus cereus and its application to the enzymatic hydrolysis of lysophospholipids.
Topics: Bacillus cereus; Hydrolysis; Kinetics; Lysophosphatidylcholines; Lysophospholipids; Octoxynol; Phosphorylcholine; Platelet Activating Factor; Sphingomyelin Phosphodiesterase; Time Factors | 2004 |
An intact phosphocholine binding site is necessary for transgenic rabbit C-reactive protein to protect mice against challenge with platelet-activating factor.
Topics: Animals; Binding Sites; C-Reactive Protein; Complement Activation; Dietary Carbohydrates; Dietary Proteins; Glutamic Acid; Lysine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenylalanine; Phosphorylcholine; Platelet Activating Factor; Protein Binding; Rabbits; Survival Analysis; Tyrosine | 2005 |
Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor.
Topics: Cell Cycle Proteins; Chemotaxis; Diterpenes; Fibrinolytic Agents; Flow Cytometry; Ginkgolides; Humans; Interferon-alpha; Interleukins; Killer Cells, Natural; Lactones; Lymphocyte Activation; Lysophosphatidylcholines; Pertussis Toxin; Phosphorylcholine; Platelet Activating Factor; Receptors, G-Protein-Coupled; Receptors, IgG; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sphingosine | 2005 |
Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation.
Topics: Animals; Bacterial Adhesion; Blood Platelets; Cattle; Pasteurellaceae; Phosphorylcholine; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction | 2007 |
Natural antibodies against phosphorylcholine as potential protective factors in SLE.
Topics: Adult; Autoantibodies; Binding, Competitive; Cardiovascular Diseases; Cross Reactions; Endothelium, Vascular; Female; Hemocyanins; Humans; Immunoglobulin G; Intercellular Adhesion Molecule-1; Lupus Erythematosus, Systemic; Middle Aged; Phosphorylcholine; Platelet Activating Factor; Serum Albumin, Bovine; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 2008 |
Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.
Topics: Animals; Antioxidants; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylcholine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Radiation Tolerance; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Skin; Tumor Necrosis Factor-alpha; Ultraviolet Rays; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group A Protein | 2012 |
Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.
Topics: Animals; Bacterial Proteins; Carrier Proteins; Carrier State; Cell Wall; Haemophilus Infections; Haemophilus influenzae; Humans; Immune Evasion; Immunity, Innate; Immunoglobulin D; Lipoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Mimicry; N-Formylmethionine Leucyl-Phenylalanine; Nasal Cavity; Neutropenia; Neutrophil Activation; Neutrophils; Phagocytosis; Phosphorylcholine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumococcal Infections; Proteolysis; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Species Specificity; Streptococcus pneumoniae | 2015 |
Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo.
Topics: Adult; Aspartic Acid; beta-Thromboglobulin; Case-Control Studies; Female; Glycerol; Humans; Lipidomics; Lysophosphatidylcholines; Male; Metabolome; Phosphorylcholine; Platelet Activating Factor; Platelet Factor 4; Succinic Acid; Vitiligo; Young Adult | 2019 |